6 Undervalued Health Care Equipment & Supplies Stocks for Friday, November 22
Discover the top 6 undervalued Health Care Equipment & Supplies stocks for Friday, November 22 based on AAII’s Stock Grades.Aneeqa Nadeem
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, Germany, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices for individuals with spinal cord injury; ReStore Exo-Suit, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals’ post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as ReWalk Robotics Ltd. and changed its name to Lifeward Ltd. in September 2024. Lifeward Ltd. was incorporated in 2001 and is based in Yokneam Illit, Israel.
Commentary & Analysis
6 Undervalued Health Care Equipment & Supplies Stocks for Thursday, October 17
Discover the top 6 undervalued Health Care Equipment & Supplies stocks for Thursday, October 17 based on AAII’s Stock Grades.Omar Beirat
3 Undervalued Medical Equipment, Supplies & Distribution Stocks for Wednesday, August 28
Discover the top 3 undervalued Medical Equipment, Supplies & Distribution stocks for Wednesday, August 28 based on AAII’s Stock Grades.Omar Beirat
5 Undervalued Medical Equipment, Supplies & Distribution Stocks for Thursday, April 25
Discover the top 5 undervalued Medical Equipment, Supplies & Distribution stocks for Thursday, April 25 based on AAII’s Stock Grades.Jack Gilleland
3 Undervalued Medical Equipment, Supplies & Distribution Stocks for Friday, March 15
Discover the top 3 undervalued Medical Equipment, Supplies & Distribution stocks for Friday, March 15 based on AAII’s Stock Grades.Jack Gilleland
Financial Summary
| Share Statistics | LFWD | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $19.6 | $372.5 | 10% |
|
| Shares Out (Mil) | 2.8 | 40.8 | 10% |
|
| Institutional Ownership | 69.0% | 83.3% | 42% |
|
| Float (Mil) | 1.6 | 35.1 | 4% |
|
| Beta | 0.39 | 0.87 | 22% |
|
| Avg Daily Volume (000s) | 5 | 287 | 14% |
|
| Price Change (52-week) |
(1.6%) | 63.4% | 49% |
|
| Growth | LFWD | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 38.0% | 11.8% | 93% |
|
| Net Income (5yr) | (8.9%) | (5.7%) | 30% |
|
| EPS (5yr) | 24.3% | 10.2% | 74 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (16.9%) | (15.5%) | 42% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 1 | 1 | 1 | |
| Current EPS | ($1.040) | ($5.020) | ($0.860) | |
| Month Ago EPS | ($1.040) | ($5.020) | ($0.860) | |
| # Rev Up | 1 | 1 | 1 | |
| # Rev Down | 0 | 0 | 0 | |
| Three Months Ago EPS | ($0.940) | ($4.580) | ($1.780) | |
| Year/Year Chg | (74.8%) | (70.7%) | (98.3%) | |
| Financials | LFWD | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $22 | $123 | 13% |
|
| Net Income (TTM) (Mil) | ($31) | ($9) | 20% |
|
| EPS (TTM) | ($17.003) | ($0.400) | 3% |
|
| Operating Cash Flow (TTM) (Mil) | ($17) | ($3) | 16% |
|
| Net Cash Flow (TTM) (Mil) | $4 | $1 | 51% |
|
| Long-Term Debt (Q1) (Mil) | $6 | $23 | 26% |
|
| Enterprise Value (Q1) (Mil) | $18 | $376 | 10% |
|
| Valuation | LFWD | Industry Median |
Percentile (All Stocks) |
|
| P/B | 1.60 | 2.79 | 43% |
|
| P/E | na | 25.7 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.5 | na |
|
| Ratios | LFWD | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 36.0% | 58.7% | 44% |
|
| Net Margin | (141.3%) | (6.9%) | 6% |
|
| ROA | (99.8%) | (12.3%) | 6% |
|
| ROE | (225.6%) | (11.1%) | 4% |
|
| Liabilities to Assets | 65.1% | 46.6% | 60% |
|
| F-Score | 4 | 4 | 33% |
|
Lifeward Ltd. did not pass any screens on 9/16/2026.
